After the vaccine of two companies in the war against the Coronavirus has been approved for emergency use, it may be difficult for the vaccine companies standing in front lines to be tested. There may be a problem with getting volunteers for their vaccines. It is known that on January 3 of this year, DCGI approved the Oxford Vaccine and indigenous Covaxin made at Serum Institute. Companies say recruitment has been adversely affected due to the news of the early availability of the vaccine.
Dr. V Krishna Mohan of Bharat Biotech said in a webinar, "There are several press releases without getting approval for emergency use, saying that their vaccine will be available soon." This is going to cause a lot of difficulty in recruitment, because most people are thinking about whether they should take part in clinical trials or not. After all, the vaccine is going to come soon. " Trials are taking place at the same time when the work of approving vaccines for emergency use is also going on in the country.
'Big challenge for India biotech'
He said that the challenge for Bharat Biotech was huge, as they were focusing on the older age group. He said that the oldest person to enroll for the covariate trial was 97. Mohan said, "Hospitals have also asked us whether it is morally right to continue clinical trials even when you have received emergency use. These questions should be answered. "Let us know that at least six human trials of corona vaccines are going on in the country. This is Zydus Cadila, which has recently started a third phase trial. Russia has Sputnik 5, whose second and third phase trials are being conducted by Dr. Reddy.
There is also an ongoing trial of these vaccines
Serum Institute of India also has the second vaccine Novavax, which is undergoing Phase II trials. Biological E and Genova are testing the first phase of their vaccine. Apart from this, work is also underway on another biotech vaccine of Bharat Biotech. Cadila Healthcare Chairperson Dr. Pankaj Patel also believes that recruitment time is going to be very challenging. He says the challenge will be to meet recruitment speed and volunteers. At the same time, there is also a concern that after the introduction of the vaccine, the weak people will get vaccinated soon.
An important meeting of the Shanghai Cooperation Organization is being held in New Delhi on Monda
Why did Russia attack Ukraine and what does Putin want?
For several months, Russian President Vladimir Putin denied any plans to attack Ukraine. But on T
After all the leaks, Nothing has finally launched its new phone Nothing Phone 2. This phone is an
The firebrand leader of the Bharatiya Janata Party (BJP) and Union Minister Giriraj Singh have hi
Christian monastery before the rise of Islam found in UAE, likely to be 1400 years old
An ancient Christian monastery dating back to many years before Islam spread across the Arabian P
Order all the students who appear in the board examinations for the session 2020-21 to be vaccina
Keeping in mind that the sentiments of crores of devotees of Tirupati are being affected by the a
Nepal worry of second wave of Corona, India's 22 entry points closed
Neighboring Nepal has also been alerted by the second wave of Corona released in India. The gover
Congress leader Rahul Gandhi has termed the new draft guidelines of the University Grants Commiss
Fans are eagerly waiting for the trailer of Kartik Aaryan's film 'Bhool Bhulaiyaa 3'. The trailer
